NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 84 filers reported holding NOVAVAX INC in Q3 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,620,408 | +6.0% | 522,939 | -60.0% | 0.14% | +22.0% |
| Q1 2024 | $6,248,416 | +85.7% | 1,307,200 | +86.5% | 0.12% | +57.3% |
| Q4 2023 | $3,364,800 | -0.9% | 701,000 | +49.5% | 0.08% | -6.2% |
| Q3 2023 | $3,394,112 | +11.8% | 468,800 | +14.7% | 0.08% | -9.1% |
| Q2 2023 | $3,036,641 | -37.8% | 408,700 | -42.0% | 0.09% | -40.9% |
| Q1 2023 | $4,884,957 | +494.0% | 704,900 | +781.1% | 0.15% | +496.0% |
| Q4 2022 | $822,400 | -97.3% | 80,000 | -62.1% | 0.02% | -98.1% |
| Q4 2021 | $30,230,000 | +191.7% | 211,300 | +322.6% | 1.29% | +144.2% |
| Q3 2021 | $10,365,000 | +147.5% | 50,000 | +33.1% | 0.53% | +242.2% |
| Q4 2020 | $4,188,000 | +320.9% | 37,562 | -85.0% | 0.15% | +327.8% |
| Q4 2019 | $995,000 | -20.7% | 250,000 | 0.0% | 0.04% | -12.2% |
| Q3 2019 | $1,255,000 | – | 250,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
| Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
| Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
| Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
| Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
| TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
| Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
| SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |